Distillate Capital Partners LLC has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $1.75 Billion distributed in 117 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Unitedhealth Group Inc with a value of $44.8M, Merck & Co., Inc. with a value of $44.8M, Johnson & Johnson with a value of $43.3M, Abb Vie Inc. with a value of $42.5M, and T Mobile Us, Inc. with a value of $37M.

Examining the 13F form we can see an decrease of $86.8M in the current position value, from $1.84B to 1.75B.

Below you can find more details about Distillate Capital Partners LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.75 Billion
Healthcare: $414 Million
Technology: $372 Million
Industrials: $269 Million
Consumer Cyclical: $216 Million
Consumer Defensive: $152 Million
Energy: $125 Million
Communication Services: $101 Million
Financial Services: $58.9 Million
Other: $44.2 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 117
  • Current Value $1.75 Billion
  • Prior Value $1.84 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 13, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 20 stocks
  • Additional Purchases 7 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 85 stocks
Track This Portfolio

Track Distillate Capital Partners LLC Portfolio

Follow Distillate Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Distillate Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Distillate Capital Partners LLC with notifications on news.